Suppr超能文献

放射技术在口咽癌治疗中的作用

Effect of radiation techniques in treatment of oropharynx cancer.

作者信息

Rusthoven Kyle E, Raben David, Ballonoff Ari, Kane Madeleine, Song John I, Chen Changhu

机构信息

Department of Radiation Oncology, University of Colorado Denver, Aurora, Colorado 80045-0508, USA.

出版信息

Laryngoscope. 2008 Apr;118(4):635-9. doi: 10.1097/MLG.0b013e31815fdf0e.

Abstract

OBJECTIVES

To compare the toxicity and outcomes of three radiotherapy techniques-three-dimensional conformal (3D-RT), accelerated fractionation with concomitant boost (AFxCB), and intensity modulated radiotherapy (IMRT)-in the combined modality treatment of stage III-IV squamous cell carcinoma (SCC) of the oropharynx.

STUDY DESIGN

Retrospective review.

METHODS

Between 1998 and 2007, a total of 87 patients were treated; 23 were treated with 3D-RT, 32 with AFxCB, and 32 with IMRT. Systemic therapy consisted of platinum-based chemotherapy in 81 and anti-epidermal growth factor receptor (anti-EGFR)-targeted therapy in 6 cases. Median radiotherapy doses were 70Gy with 3D-RT, 72Gy with AFxCB, and 69.3Gy with IMRT. Locoregional control, survival outcomes, and feeding tube (PEG) dependence were compared using log-rank method. The incidence of acute mucositis and skin reaction, and grade > or = 2 xerostomia at 6, 12, and 18 months after radiotherapy was compared using Fisher's exact test.

RESULTS

Median follow-up was 24 months (range 3 to 103 months) for living patients. Two-year overall survival (OS), disease-free survival (DFS), and locoregional control (LRC) were 77.3%, 69.5%, and 86.4%, respectively. There was a trend toward improvement in LRC in patients treated with IMRT. Acute grade > or = 3 skin and mucosal toxicity were significantly lower with IMRT compared to AFxCB (P < .001). Grade > or = 2 xerostomia was significantly reduced with IMRT compared to AFxCB and 3D-RT (P < .001). There was no difference in the actuarial rate of PEG dependence (P = .96).

CONCLUSIONS

Compared to AFxCB and 3D-RT, IMRT confers an improvement in toxicity and appears to have similar efficacy in patients with SCC of the oropharynx.

摘要

目的

比较三维适形放疗(3D-RT)、加速分割同步推量放疗(AFxCB)和调强放疗(IMRT)这三种放疗技术在口咽Ⅲ-Ⅳ期鳞状细胞癌(SCC)综合治疗中的毒性及治疗效果。

研究设计

回顾性研究。

方法

1998年至2007年间,共治疗87例患者;23例接受3D-RT治疗,32例接受AFxCB治疗,32例接受IMRT治疗。全身治疗包括81例接受铂类化疗,6例接受抗表皮生长因子受体(anti-EGFR)靶向治疗。3D-RT的中位放疗剂量为70Gy,AFxCB为72Gy,IMRT为69.3Gy。采用对数秩检验比较局部区域控制、生存结果和胃造瘘管(PEG)依赖情况。采用Fisher精确检验比较放疗后6、12和18个月时急性黏膜炎和皮肤反应的发生率以及≥2级口干的发生率。

结果

存活患者的中位随访时间为24个月(范围3至103个月)。两年总生存率(OS)、无病生存率(DFS)和局部区域控制率(LRC)分别为77.3%、69.5%和86.4%。接受IMRT治疗的患者LRC有改善趋势。与AFxCB相比,IMRT的急性≥3级皮肤和黏膜毒性显著更低(P<.001)。与AFxCB和3D-RT相比,IMRT的≥2级口干显著减少(P<.001)。PEG依赖的精算发生率无差异(P =.96)。

结论

与AFxCB和3D-RT相比,IMRT可改善毒性,且对口咽SCC患者似乎具有相似的疗效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验